Rancati; Fabio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rancati; Fabio.The latest application filed is for "tyrosine amide derivatives as rho- kinase inhibitors".

Company Profile

9.20.23

Rancati; Fabio - Parma IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Azaindole derivatives as Rho-kinase inhibitors Grant 11,332,468 - Accetta , et al. May 17, 2	2022-05-17
Tyrosine analogues derivatives as Rho-kinase inhibitors Grant 11,147,812 - Accetta , et al. October 19, 2	2021-10-19
Tyrosine Amide Derivatives As Rho- Kinase Inhibitors App 20210284639 - ACCETTA; Alessandro ; et al.	2021-09-16
Azaindole Derivatives As Rho-kinase Inhibitors App 20210253568 - ACCETTA; Alessandro ; et al.	2021-08-19
Tyrosine amide derivatives as Rho-Kinase inhibitors Grant 10,954,236 - Accetta , et al. March 23, 2	2021-03-23
Tyrosine Analogues Derivatives As Rho-kinase Inhibitors App 20210023080 - ACCETTA; Alessandro ; et al.	2021-01-28
Azaindole Derivatives As Rho- Kinase Inhibitors App 20200392133 - ACCETTA; Alessandro ; et al.	2020-12-17
Meta Tyrosine Derivatives As Rho-kinase Inhibitors App 20200377500 - ACCETTA; Alessandro ; et al.	2020-12-03
Oxadiazole Derivatives As Rho-kinase Inhibitors App 20200331912 - ACCETTA; Alessandro ; et al.	2020-10-22
Tyrosine Amide Derivatives As Rho- Kinase Inhibitors App 20200079774 - ACCETTA; Alessandro ; et al.	2020-03-12
Bicyclic dihydropyrimidine-carboxamide derivatives as Rho-Kinase inhibitors Grant 10,584,128 - Accetta , et al.	2020-03-10
Tyrosine amide derivatives as Rho-kinase inhibitors Grant 10,501,461 - Accetta , et al. Dec	2019-12-10
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 10,196,386 - Rancati , et al. Fe	2019-02-05
Tyrosine Amide Derivatives As Rho- Kinase Inhibitors App 20180215758 - Accetta; Alessandro ; et al.	2018-08-02
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Grant 10,004,728 - Rancati , et al. June 26, 2	2018-06-26
Bicyclic Dihydropyrimidine-carboxamide Derivatives As Rho- Kinase Inhibitors App 20180170939 - Accetta; Alessandro ; et al.	2018-06-21
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Grant 9,932,338 - Carzaniga , et al. April 3, 2	2018-04-03
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20180016267 - RANCATI; Fabio ; et al.	2018-01-18
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20170158694 - CARZANIGA; Laura ; et al.	2017-06-08
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 9,662,323 - Carzaniga , et al. May 30, 2	2017-05-30
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20170119753 - RANCATI; Fabio ; et al.	2017-05-04
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Grant 9,579,314 - Rancati , et al. February 28, 2	2017-02-28
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20160346271 - CARZANIGA; Laura ; et al.	2016-12-01
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 9,453,013 - Rancati , et al. September 27, 2	2016-09-27
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20160235734 - RANCATI; Fabio ; et al.	2016-08-18
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 9,371,318 - Rancati , et al. June 21, 2	2016-06-21
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20150139916 - RANCATI; Fabio ; et al.	2015-05-21
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20150133491 - RANCATI; Fabio ; et al.	2015-05-14
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 9,012,644 - Rancati , et al. April 21, 2	2015-04-21
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 8,987,299 - Rancati , et al. March 24, 2	2015-03-24
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 8,980,913 - Rancati , et al. March 17, 2	2015-03-17
Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activity Grant 8,877,774 - Rancati , et al. November 4, 2	2014-11-04
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20140161736 - Rancati; Fabio ; et al.	2014-06-12
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20140163066 - RANCATI; Fabio ; et al.	2014-06-12
Pyrrolidine compounds,pharmaceutical compositions containing the same, devices containing the same, and methods of treating asthma or chronic obstructive pulmonary disease by administering the same Grant 8,481,517 - Ghidini , et al. July 9, 2	2013-07-09
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20130045169 - Rancati; Fabio ; et al.	2013-02-21
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20130034504 - RANCATI; Fabio ; et al.	2013-02-07
Pyrrolidine Derivatives App 20110201580 - GHIDINI; Eleonora ; et al.	2011-08-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.